CONSULT.Outcome publishedConsultation · gov.uk
Statutory scheme to control cost of branded medicines
Proposed changes to the statutory scheme to control the costs of branded health service medicines.
Last fetched 03 May 2026 · gov.uk
Detail
The government is consulting on proposals to amend the statutory scheme that controls the prices of branded health service medicines. This builds on a previous consultation run in 2015.
The aim is to achieve alignment with the current voluntary pharmaceutical price regulation scheme (PPRS), agreed in 2014.
The main proposals in the consultation are:
- the introduction of a payment system similar to that in the 2014 PPRS
- changes to the provisions on maximum prices, including removing the requirement for a 15% price cut
- changes to the information requirements placed on companies
Draft regulations and a draft impact assessment are published alongside this consultation.
Documents
Proposed changes to the statutory scheme to control the cost of branded health service medicinesapplication/pdfDraft regulations for the consultation on changes to the statutory scheme to control costs of branded health service medicinesapplication/pdfImpact assessment - statutory scheme branded medicines pricingapplication/pdfConsultation response: Proposed changes to the statutory scheme to control the cost of branded health service medicinesapplication/pdf